Data as of Jul 25
| -1.48 / -2.96%|
The 25 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 54.53, with a high estimate of 66.55 and a low estimate of 46.51. The median estimate represents a +12.21% increase from the last price of 48.60.
The current consensus among 28 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.